<code id='FADDA3967A'></code><style id='FADDA3967A'></style>
    • <acronym id='FADDA3967A'></acronym>
      <center id='FADDA3967A'><center id='FADDA3967A'><tfoot id='FADDA3967A'></tfoot></center><abbr id='FADDA3967A'><dir id='FADDA3967A'><tfoot id='FADDA3967A'></tfoot><noframes id='FADDA3967A'>

    • <optgroup id='FADDA3967A'><strike id='FADDA3967A'><sup id='FADDA3967A'></sup></strike><code id='FADDA3967A'></code></optgroup>
        1. <b id='FADDA3967A'><label id='FADDA3967A'><select id='FADDA3967A'><dt id='FADDA3967A'><span id='FADDA3967A'></span></dt></select></label></b><u id='FADDA3967A'></u>
          <i id='FADDA3967A'><strike id='FADDA3967A'><tt id='FADDA3967A'><pre id='FADDA3967A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:484
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          5 takeaways from STAT's examination of Zynex Medical
          5 takeaways from STAT's examination of Zynex Medical

          ApileofZynexMedicalbatteriesandelectrodepadsKayanaSzymczakforSTATSendingpatientsheapsofmedicalsuppli

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Listen: Your guide to Wegovy's blockbuster heart study

          IsWegovythefutureofcardiology?CanNovoNordiskevermakeenoughofit?AndwillthereeverbeanAppleofpharma?Wec